SELLAS Life Sciences is at the center of a debate over its event-driven Phase 3 REGAL trial for GPS in AML CR2 patients. Read ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...

Fueling for your race isn’t just important for a marathon. As annoying as it may be to get food or liquids down after running ...

A patient with type 1 diabetes received genetically modified allogeneic islets and no immunosuppression. Results obtained ...

Christopher A. Farrell is a bestselling author, and former Wall Street trader and market maker with nearly 30 years of experience, trading over $20 billion in transaction value over his career. Dr.

Objective The aim of the study was to assess the psychometric properties of the Afaan Oromoo version of Generalised Anxiety ...

Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...